Disturbing one single compound that ASTX never really played up. They have added several new compounds:
AT26893 HCV which will enter the clinics in 1H13
AZD5363-four trials by astra zenca.
To focus in on this one single compound by max,md,batzem all the time. Just strange. It was not a game changer. Figure it was scrubbed.
I like the idea of the IAP drug they are working on. It's for inflamatory tumor types. It has a oral efficacy. We have more drugs than we can follow right now. The big boys are advancing most of them and that is a great sign. But you keep your eyes open looking for at7519. Small brains have few other choices. You know how I know this, not one of the so called other id's out there has any real thoughts. They just reguritate the same old ones. Brainfarts.